Abstract:Demethylzeylasteral (DEM), a class of terpenoids isolated from natural plants, frequently exhibits moderate or limited inhibitory effect on tumor growth across multiple cancer types. Thus, here we attempted to elevate the anti-tumor efficacy of DEM by altering active groups in its chemical structure. Initially, we synthesized a series of novel DEM derivatives 1 – 21 through performing a series of modifications of its phenolic hydroxyl groups at C-2/3, C-4 and C-29 positions. The anti-proliferative activities of these new compounds were subsequently assessed using three human cancer cell line models (A549, HCT116 and HeLa) and CCK-8 assay. Our data showed that compared to original DEM compound, derivative 7 exhibited remarkable inhibition effect on A549 (16.73 ± 1.07 μM), HCT116 (16.26 ± 1.94 μM) and HeLa (17.07 ± 1.09 μM), almost reaching to the same level of DOX. Moreover, the structure-activity relationships (SARs) of the synthesized DEM derivatives were discussed in detail. We found that treatment with derivative 7 only led to moderate cell cycle arrest at S-phase in a concentration-dependent manner. Meanwhile, derivative 7 treatment markedly induced apoptosis in tumor cells. Consistent with this observation, our subsequent docking analysis showed that derivative 7 is capable of activating caspase-3 through interaction with the His 121 and Gly 122 residues of the enzyme. Overall, we have developed a new series of DEM derivatives with elevated anti-tumor efficacy relative to its parent form. The results suggested that derivative 7 has great potential to be employed as an anticancer agent candidate for natural product-based cancer chemotherapy.

Synthesis, Characterization, and in Vitro Antiproliferative Activity of Novel Β-Elemene Monosubstituted Derivatives

Synthesis and Antitumor Activity of Hederagenin Derivatives

Synthesis and biological activity of novel 1,3,4-oxadiazole derivatives containing a pyrazole moiety

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Synthesis and Estrogen-Like Activity of Resveratrol Analogues

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis and biological activity evaluation of emodin quaternary ammonium salt derivatives as potential anticancer agents

Design, Synthesis and Preliminary Antiproliferative Activity Studies of New Diheteroaryl Thioether Derivatives

Synthesis and antiproliferative activity of novel erythromycin derivatives

Design, synthesis and antitumor efficacy evaluation of a series of novel β-elemene-based macrocycles

Synthesis and Preliminary Studies of Biological Activity

The Synthesis of Ursolic Acid Derivatives with Cytotoxic Activity and the Investigation of Their Preliminary Mechanism of Action.

Design, Synthesis and Biological Evaluation of Novel Indone Derivatives As Selective ERβ Modulators

Synthesis, characterization and in vitro biological evaluation of two matrine derivatives

Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Synthesis, SAR and pharmacological characterization of novel anthraquinone cation compounds as potential anticancer agents

Synthesis, in vitro Antimicrobial, and Cytotoxic Activities of New 1,3,4-Oxadiazin-5(6H)-one Derivatives from Dehydroabietic Acid: New Oxadiazine Derivatives of Dehydroabietic Acid

Synthesis and biological evaluation of novel demethylzeylasteral derivatives as potential anticancer agents

Synthesis and antiproliferative activities of polymethoxyflavones aminoalkyl and amino acid derivatives

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.